NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Logility Supply Chain Solutions, Inc. (NASDAQ: LGTY)’s sale to Aptean for $14.30 per share in cash. If you are a Logility shareholder, click here to learn more about your legal rights and options.
Aspen Technology, Inc. (NASDAQ: AZPN)’s sale to Emerson for $265.00 per share in cash. If you are an Aspen shareholder, click here to learn more about your rights and options.
Redwire Corporation (NYSE: RDW)’s merger with Edge Autonomy. Redwire will pay the purchase price for the acquisition of Edge Autonomy in a combination of $150 million in cash and $775 million in shares of Redwire common stock. If you are a Redwire shareholder, click here to learn more about your rights and options.
Quanterix Corporation (NASDAQ: QTRX)’s merger with Akoya Biosciences, Inc. Upon completion of the proposed transaction, Quanterix shareholders will own approximately 70% of the combined company. If you are a Quanterix shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
One World Trade Center
85th Floor
New York, NY 10007
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
- Roche’s fenebrutinib maintains near-complete suppression of disease activity and disability progression for up to two years in people with relapsing multiple sclerosis - May 30, 2025
- RomReal: First Quarter (Q1) 2025 Results and Investor Presentation - May 30, 2025
- High Arctic Overseas Announces 2025 First Quarter Results - May 30, 2025
